Vaccination information, motivations, and barriers in the context of meningococcal serogroup A conjugate vaccine introduction: A qualitative assessment among caregivers in Burkina Faso, 2018
| Autor: | Ryan T. Novak, Heidi M Soeters, Cynthia Hatcher, Jenny A. Walldorf, Alpha Oumar Diallo, Isaïe Medah, Robert L. Zoma, Jaymin C. Patel, Terri B. Hyde, Ludovic Kambou, Félix Tarbangdo, Brooke Noel Aksnes, Mohamed F Jalloh, Imran Mirza, Sansan Hien, Sylvain F. Nkwenkeu, Soukeynatou Fall, Flavien Aké, Cesaire Ky |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Vaccination challenges Meningococcal Vaccines Context (language use) Meningitis Meningococcal Serogroup Article Conjugate vaccine Burkina Faso Health care Humans Medicine Misinformation Immunization schedule Child Measles vaccine Motivation Vaccines Conjugate General Veterinary General Immunology and Microbiology business.industry Personal awareness Vaccination Public Health Environmental and Occupational Health Infant Vaccine introduction Focus group Infectious Diseases Caregivers Family medicine Meningococcal serogroup A conjugate vaccine Molecular Medicine business |
| Zdroj: | Vaccine |
| ISSN: | 0264-410X |
| Popis: | Highlights • Caregivers were motivated to vaccinate their children against measles and meningitis. • Motivations were driven by vaccine communication and perceived disease protection. • Health workers were trusted sources of vaccine information. • Barriers included vaccine unavailability, knowledge gaps, and practical constraints. • Vaccine uptake could be enhanced by using trusted messengers and addressing barriers. Background In March 2017, Burkina Faso introduced meningococcal serogroup A conjugate vaccine (MACV) into the Expanded Programme on Immunization. MACV is administered to children aged 15–18 months, concomitantly with the second dose of measles-containing vaccine (MCV2). One year after MACV introduction, we assessed the sources and content of immunization information available to caregivers and explored motivations and barriers that influence their decision to seek MACV for their children. Methods Twenty-four focus group discussions (FGDs) were conducted with caregivers of children eligible for MACV and MCV2. Data collection occurred in February–March 2018 in four purposively selected districts, each from a separate geographic region; within each district, caregivers were stratified into groups based on whether their children were unvaccinated or vaccinated with MACV. FGDs were recorded and transcribed. Transcripts were coded and analyzed using qualitative content analysis. Results We identified many different sources and content of information about MACV and MCV2 available to caregivers. Healthcare workers were most commonly cited as the main sources of information; caregivers also received information from other caregivers in the community. Caregivers’ motivations to seek MACV for their children were driven by personal awareness, engagements with trusted messengers, and perceived protective benefits of MACV against meningitis. Barriers to MACV and MCV2 uptake were linked to the unavailability of vaccines, immunization personnel not providing doses, knowledge gaps about the 15–18 month visit, practical constraints, past negative experiences, sociocultural influences, and misinformation, including misunderstanding about the need for MCV2. Conclusions MACV and MCV2 uptake may be enhanced by addressing vaccination barriers and effectively communicating vaccination information and benefits through trusted messengers such as healthcare workers and other caregivers in the community. Educating healthcare workers to avoid withholding vaccines, likely due to fear of wastage, may help reduce missed opportunities for vaccination. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect